- Bloomberg•14 hours ago
Mylan NV engaged in a campaign to squash a rival to its EpiPen allergy treatment and artificially inflate the price of the drug to maintain a market monopoly, French drugmaker Sanofi said in a lawsuit ...
- TheStreet.com•14 hours ago
French multinational pharmaceutical company Sanofi on Monday filed a lawsuit against U.S. company Mylan.
- Reuters•15 hours ago
France's Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment, which has been at the center of a public debate over drug prices. In a lawsuit filed in federal court in Trenton, New Jersey, Sanofi said Mylan caused it to lose hundreds of millions of dollars in sales by erecting barriers to U.S. consumers' access to and use of a rival product, Auvi-Q.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||45.72 - 46.16|
|52 Week Range||36.81 - 46.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.75|
|Dividend & Yield||1.58 (3.46%)|
|1y Target Est||N/A|